MAPK8 and neuroblastoma: Based on available evidence, this is the first comprehensive study that investigates the antineoplastic effect of JNK inhibition in the NB in vitro model, a SH-SY5Y human neuroblastoma cell line, using the pharmacological inhibition of JNK signalling by JNK inhibitor AS601245 (JNK inhibitor V, JNK V).